Do you want to read an article? Please log in or register.
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial
COPD
![](https://cdn.healthbook.network/wp-content/uploads/2018/03/like_hb.png)